Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
Data Access and Storage
Authors may be asked to provide the research data supporting their paper for editorial review and/or to comply with the open data requirements of the journal. Authors should be prepared to provide public access to such data, if practicable, and should be prepared to retain such data for a reasonable number of years after publication. Authors may refer to Authors Guidelines of «Clinical Microbiology and Antimicrobial Chemotherapy» for further details.
Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or statements of others, that this has been appropriately cited or quoted. Plagiarism takes many forms, all variants of it are unethical behavior and impermissible.
Multiple, Redundant or Concurrent Publication
Authors should not submit the same manuscript, simultaneously to more than the journal «Clinical Microbiology and Antimicrobial Chemotherapy». An author should not submit for consideration in another journal a paper that has been published previously in the journal «Clinical Microbiology and Antimicrobial Chemotherapy». Secondary publication of material may be justifiable and beneficial, especially when intended to disseminate important information to the widest possible audience, but is limited to a certain list in ICMJE recommendation: www.icmje.org.
Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made substantial contributions should be listed as co-authors. The authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The corresponding author should ensure that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
Risks, Human or Animal Subjects of the Study
The author must clearly identify in the manuscript if the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use. The author should ensure that the manuscript contains a statement that all procedures involving the use of animal or human subjects were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
Policy of Disclosure and Conflicts of Interests
All authors should disclose any financial and personal relationships with other people or organizations that could be viewed as inappropriately influencing the manuscript. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest possible stage.
Fundamental errors in published works
The authors must promptly notify the editor of «Clinical microbiology and Antimicrobial Chemotherapy» when the author discovers a significant error or inaccuracy in the own published manuscript and cooperates with the editor to retract or correct the paper. It is the obligation of the author to cooperate with the editor, if the editor or the publisher learn from a third party that a published materials contain an error.